Navigation Links
Herborium Group Reports Record 6 Month Revenues

FORT LEE, N.J., June 27, 2012 /PRNewswire/ -- Herborium Group, Inc., ( HBRM), a Botanical Therapeutics® Company announces today that its revenues   from AcnEase®, all botanical, proprietary acne treatment, grew over 25 percent in  the first  six months  of 2012  in comparison to the same period of 2011.  Gross Profit increased 4.5%  .

"We are truly pleased by the accelerated  sales  of AcnEase that we  have achieved during  the first six months of this  year.  Considering a difficult economic climate, our growth is even more impressive and proves that Herborium's marketing strategy is working. Social Media Campaign that we deployed  last fall increased  on-line traffic  for AcnEase®  87%, and number of AcnEase  Facebook followers  by 49%.  There is over 60 million people with acne in the USA alone. We have also received a number of distributorship inquiries to sell AcnEase that we are presently working to complete. We expect that a success of our  digital marketing will result in further growth of revenues and increase of our market share leading to a record year for Herborium. Expected launch of Herborium sexual health and energy products in the Fall should add to this growth," commented Dr. Agnes  P. Olszewski,  Chairman and CEO of Herborium.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company sales its products in the US and Europe. For more information, please visit and

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire:


SOURCE Herborium Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Herborium Announces Continuing Progress In Key Strategic Initiatives
2. InspireMD to Present at Harvard Investors Group on June 27 in New York
3. Forbes Names Pharmalot, a UBM Canon Pharmaceutical Media Group Brand, as a Top Social Media Influencer
4. Billians HealthDATA Expands Market Coverage to Include Physician Group Practices
5. PatientPay from Zepherella Makes Patient Registration and Payment Pre-Authorization Faster, Easier for Physician Groups
6. American Society of Hematology joins European Hematology Association, Patient Groups in Issuing International Call to Action to Alleviate Drug Shortages
7. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
8. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
9. SurgiCount Medical Awarded Contract From HealthTrust Purchasing Group for the Safety-Sponge® System
10. Pharmaceuticals - Global Group of Eight (G8) Industry Guide
11. Early Coronary Artery Healing Advantage of OrbusNeichs Combo Dual Therapy Stent™ Compared to the TAXUS® Stent Shown in Two Clinical Trial Subgroup Analyses
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
Breaking Medicine News(10 mins):